K ainate receptors (KAR) form a class of glutamate receptors that have been implicated in epilepsy, stroke, Alzheimer's and neuropathic pain.
Introduction
KARs are found pre and postsynaptically and have been implicated in the etiology of epilepsy, as well as stroke-induced neurodegeneration and Huntington's disease. 6, 7 Epilepsy occurs when inhibitory adaptation is unable to prevent excess neural activity. The developing cortex is particularly vulnerable and a number of syndromes are associated with epilepsy at an early age. 8 Postsynaptic injection of kainic acid causes epileptiform discharges and the death of hippocampal CA3 pyramidal neurons. 9, 10 Moreover, KARs are subject to developmental and activity-dependent regulation at thalamocortical synapses and are likely to play an important role in the development of hippocampal synaptic circuits.
11-13 KARs act as excitatory glutamate-gated ion channels: KAR-mediated excitatory postsynaptic currents were first described at mossy fiber-CA3 pyramidal cell synapses, 14,15 while presynaptically, activation of KARs on inhibitory interneurons decreases GABA release which acts to enhance electrical activity, suggesting that presynaptic KARs may be epileptigeneic. 16 Notably, the GluR6 subtype of KARs can also increase neuronal excitability via metabotropic regulation of potassium channels. 17 To treat pathological conditions it will be crucial to understand the molecular mechanisms that determine localization of specific KARs to specific membrane domains.
Within KARs, there is a considerable diversity of properties, including unitary channel conductance, Ca 2 permeability and rectification, which arise from differences in receptor subunit composition and RNA editing of KARs are tetramers that can be assembled from any one of five receptor subunits encoded by two separate gene families.
The first of these includes receptor subunits GluR5, -6 and -7. Each of these subunits can form functional homomeric ion channels or heteromeric mixtures that appear to assemble promiscuously with any available subunit GluR5, -6 or -7. [21] [22] [23] Alternative splicing of GluR5 yields two isoforms:
21 GluR5-1 and GluR5-2, which has three additional splice variants possessing distinct C-terminal sequences. The shortest variant is designated GluR5-2a, while additional exons located in the C-terminal region give rise to GluR5-2b and GluR5-2c; these variants share a C-terminal type 1 PDZ-binding domain that is absent in GluR5-2a. 18 The second gene family consists of KA1 and KA2 subunits that are functional only when expressed as heteromeric assemblies with GluR5, -6 or -7. 23, 24 Alternative splicing and RNA editing of ionotropic glutamate receptors play important roles in receptor assembly and trafficking. [25] [26] [27] Regulatory steps in the assembly of KA2-containing KARs are governed by at least two trafficking signals located in the cytoplasmic terminal (C-tail) of the KA2 subunit. The first is an arginine-rich motif which operates as an endoplasmic reticulum (ER) retention signal preventing the insertion of homomeric KA2 receptors into the plasma membrane. 28 The second is a di-leucine motif which mediates the internalization and subsequent relocalization of surface-expressed KA2 subunits.
28 Similarly, GluR5-2b carries a positively charged amino acid motif that acts as a novel ER retention signal. 29 In contrast, GluR6, which is highly expressed at the plasma membrane, has a forward trafficking signal in its C-terminal domain critical for ER exit.
30,31
These differences in targeting appear to convey specific roles to specific KAR subtypes: In GluR6 knockout mice, mossy fiber long-term potentiation (LTP) was reduced, whereas GluR5 knockout mice exhibited normal LTP. 32 The activation of KARs also modulates neurotransmitter release from a number of hippocampal synapses, including GABA release at inhibitory terminals that synapse onto CA1 pyramidal cells. 16, [33] [34] [35] In hippocampal slices, kainate depresses GABA-mediated synaptic inhibition and increases the firing rate of interneurons. These effects are explained by two populations of KARs in CA1 interneurons: GluR6/KA2 located in the somatodendritic compartment and GluR5-GluR6 or GluR5-KA2 at presynaptic terminals. 35 It is anticipated that this segregation of KARs will allow us to design drugs that specifically target each function.
Recent evidence suggests that the ubiquitin-proteasome pathway and synaptic activity affects the composition of postsynaptic proteins. [36] [37] [38] The addition of ubiquitin to proteins leads to a variety of fates for the tagged proteins, one of which is degradation by the 26S proteasome. 39 A family of proteins called E3 ligases determines the specificity of ubiquitin addition. E3 ligases frequently consist of a complex of proteins that act together for specific substrate binding and ubiquitin ligation activity. Two major families of E3 ligases have been described: the HECT-domain family that is defined by its homology to the C-terminus of E6-associated protein (E6AP) and the RING family that contains either an intrinsic RING-finger domain or an associated RING-finger protein subunit essential for ubiquitin ligase activity. 40 One of the best-characterized subset of the RING E3 ligases is the Skp1/Cul1/F-box protein complex (SCF), in which Cul1 binds an adaptor molecule, Skp1.
41,42 Skp1 associates with an F-box protein that in turn binds a phosphorylated substrate. The Cul1 component of the SCF E3 ligase belongs to an evolutionarily conserved family of proteins known as cullins, of which there are six closely related members (Cul1, 2, 3, 4A, 4B and 5) and three distant relatives (Cul7, Parc and APC2).
A major class of Kelch proteins, defined as containing a 6-fold tandem "kelch" element, 43 contains an N-terminal BTB/POZ domain and C-terminal kelch repeats and targets different substrates to the Cul3-Roc1 catalytic core. 44 For example, the BTB-Kelch protein Keap1, a negative regulator of the transcription factor Nrf2, binds Cul3 and Nrf2 via its BTB and kelch domains, respectively, targeting Nrf2 for ubiquitination and subsequent degradation by the proteasome. 45 The BTB-Kelch family also includes the closely related protein mayven, an actin-binding protein and gigaxonin, which is mutated in a human autosomal recessive neurodegenerative disorder named giant axonal neuropathy. 46 Mutations in E3 ubiquitin ligases have also been associated with Parkinson's disease and breast cancer. 
